|
|
|
Legacy BioDesign LLC www.legacybiodesign.com
Short Course Offerings for 2011
Legacy BioDesign is honored to be part of these various short course
offerings. We hope you will plan to attend one of them. Please feel free to
contact us with any questions or comments.
We also offer short courses in-house for clients, which can be customized to suit your needs. The links to the outlines of our standard 3-day course and two 2-day courses are shown below.
Click below to see an outline of the short courses:
Protein & Peptide Formulation & Stabilization Course 2010 Outline
Introductory Course Outline
Advanced Course Outline
Awards
Award Nomination. The manuscript from our collaboration with scientists from the Centers for Disease Control and Prevention (CDC) (“Ability of Two All Natural Products, Nootkatone and Carvacrol, to Suppress Ixodes scapularis and Amblyomma americanum (Acari: Ixodidae) in a Lyme Disease Endemic Area of New Jersey”, Marc C. Dolan, Robert A. Jordan, Terry L. Schulze, Christopher J. Schulze, Mark Cornell Manning, Daniel Ruffolo, Jason P. Schmidt, Joseph Piesman, and Joseph J. Karchesy, J. Econ. Entomol. 2009, 102: 2316-2324) was nominated for the CDC’s 2010 Charles C. Shepard award in the Prevention and Control category.
Events
Dr. Manning has been invited to make a presentation at the US Food and Drug Administration on September 26, 2011. The title of his talk will be "Self-Interaction Chromatography: Convenient Quantitation of the Colloidal Stability of Protein Therapeutics"
Susan and Mark Manning will be attending the national AAPS meeting in Washington, DC on October 26 and 27, where Mark will speak on "Product Development Issues for PEGylated Proteins"
Roundtable: State of the Art in Peptide and Protein Delivery
Thursday, Oct 27, 2011 from 9-11 AM
Moderators:
Duxin Sun, PhD, University of Michigan
Jeffrey Wang, PhD, Western University of Health Sciences
Speakers:
Wei-chiang Shen, PhD, University of Southern California
Fusion Proteins for Improving Absorption and Disposition of Protein Drugs: Transferrin as an Active Carrier Domain
Mark Manning, PhD, Legacy BioDesign, LLC
PEGylated Proteins and Peptides: Development Issues
Jeffrey Wang, PhD, Western University of Health Sciences
Lipidized Peptides and Proteins with Increased Drugability
|
|
|
|
|
|
|
